Evidence map›Paper›PMID 40464842›Full record

ReviewCancer metastasis reviews2025

The invadosome of stem-like cancer cells: metastasis machinery and targetable vulnerability.

Kelvin K Tsai

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cancer metastasis reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kelvin K TsaiLaboratory of Advanced Molecular Therapeutics, Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei City, 110301, Taiwan. tsaik@tmu.edu.tw.ORCID 0000-0002-1612-2868

Funding

National Science and Technology Council (NSTC), Taiwan NSTC 113-2314-B-038-068Taipei Medical University Wan Fang Hospital WFH 113-5433-001-500
6 · The paper itself

Abstract

Despite recent advances in targeted and immuno-therapy, metastasis still kills most cancer patients. Overcoming cancer metastasis requires a leap forward in understanding its molecular underpinnings to identify breakthrough therapeutic targets and strategies. A growing body of evidence suggests that specific subsets of cancer cells, which exhibit stem-like properties and are referred to as cancer stem cells (CSCs), are the primary drivers of cancer metastasis. How CSCs contribute to the multistep process of invasion and metastasis remains incompletely understood. Invadosomes are dynamic actin-based cellular protrusions that mediate cell invasion and pericellular proteolysis. Recent data have highlighted the highly proficient ability of CSCs to generate invadosomes, facilitating their local invasiveness, intravasation, extravasation, and metastatic colonization. This up-to-date and focused review describes the recent progress in characterizing invadosomes in embryonic cells during development and in CSCs during cancer metastasis. We summarize the molecular processes that regulate the invadosomes of CSCs. We discuss the molecules associated with the invadosome of CSCs and highlight their correlation with cancer metastasis in patients. We propose targeting the invadosomes of CSCs as a novel strategy to overcome cancer invasiveness and metastasis. This review highlights the emerging role of invadosomes in CSCs and provides a new perspective on pathobiology and cancer metastasis treatment.

Indexed as

NeoplasmsNeoplastic Stem CellsPodosomesAnimalsHumansNeoplasm InvasivenessNeoplasm MetastasisCancer stem cellInvadosomeMetastasisTherapeutic target

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.